CORDIS
EU research results

CORDIS

English EN

Advancing European Research Infrastcuture on Highly Pathogenic Agents

Objective

One of the great challenges of the 21st century is to develop the capacity to prevent and react to outbreaks caused by highly pathogenic human and animal microorganisms, which are generally characterized by a high mortality rate, unavailability of prophylactics or effective therapeutic treatment and high human-to-human transmission.
ERINHA AISBL (European Research Infrastructure on Highly Pathogenic Agents), a pan-European Research Infrastructure (RI) dedicated to the study of high-consequence pathogens of Risk Group 4 (RG4), entered into implementation phase in July 2017. It now aims to ensure its long-term sustainability to better answer societal challenges in the field of Science, Health and Security.
The overall aim of the ERINHA-Advance project is to implement actions that will contribute to the long-term sustainability of the ERINHA RI, through enlargement of its membership and partnership and strengthening the overall services offer and framework by fostering the innovation potential of the RI.
To reach these goals, the RI will focus on the following specific objectives:
1. Enlarge ERINHA’s membership and research capacities (WP2);
2. Improve users services (WP3);
3. Stimulate the innovation potential of ERINHA and identify the co-innovation opportunities with industry (WP4);
4. Strengthen the overall services framework through long-term data-management and data sharing rules, clarification of IPR regimes and definition and implementation of the quality assurance system of the RI and its national nodes (WP5);
5. Reinforce ERINHA’s European and International cooperation with relevant countries, initiatives and networks (WP2 and WP6).
By achieving these objectives, ERINHA-Advance will largely contribute to providing access to larger number of high containment facilities to European and international scientists and foster research and innovation in the field of highly infectious diseases.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS

Address

Montoyerstraat 10
1000 Brussel

Belgium

Activity type

Research Organisations

EU Contribution

€ 1 018 565

Participants (10)

Sort alphabetically

Sort by EU Contribution

Expand all

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

EU Contribution

€ 572 750

INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE

Portugal

EU Contribution

€ 275 528,75

FOLKHALSOMYNDIGHETEN

Sweden

EU Contribution

€ 381 250

NEMZETI NEPEGESZSEGUGYI KOZPONT

Hungary

EU Contribution

€ 235 668,25

ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO

Italy

EU Contribution

€ 98 426,25

INSERM TRANSFERT SA

France

EU Contribution

€ 306 625

MEDIZINISCHE UNIVERSITAT GRAZ

Austria

EU Contribution

€ 86 250

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 80 247,50

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium

EU Contribution

€ 105 243,75

BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN

Germany

EU Contribution

€ 86 250

Project information

Grant agreement ID: 824061

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2021

Funded under:

H2020-EU.1.4.1.1.

  • Overall budget:

    € 3 246 804,50

  • EU contribution

    € 3 246 804,50

Coordinated by:

EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PATHOGENIC AGENTS

Belgium